Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study

被引：0
|
作者：
Lee, Samuel S. [1 ]
Kilvert, Leah [1 ]
Liu, Hongqun [1 ]
Trepanier, Janie [2 ]
机构：
[1] Univ Calgary, Liver Unit, Calgary, AB, Canada
[2] Merck Canada, Montreal, PQ, Canada
来源：
DIGESTIVE AND LIVER DISEASE | 2016年 / 48卷 / 03期
关键词：
D O I：
10.1016/j.dld.2015.08.015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [31] HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN
    Flamm, S.
    Lawitz, E.
    Jacobson, I.
    Rubin, R.
    Bourliere, M.
    Hezode, C.
    Vierling, J.
    Niederau, C.
    Sherman, M.
    Goteti, V.
    Vilchez, R.
    Brass, C.
    Albrecht, J.
    Poordad, F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S541 - S542
  • [32] High Sustained Virologic Response (SVR) Among Genotype I Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Peginterferon Alfa-2A/Ribavirin
    Flamm, Steven L.
    Lawitz, Eric J.
    Jacobson, Ira M.
    Rubin, Raymond A.
    Bourliere, Marc
    Hezode, C.
    Vierling, J.
    Niederau, Claus
    Sherman, Morris
    Goteti, Venkata S.
    Vilchez, Regis A.
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, Fred
    GASTROENTEROLOGY, 2011, 140 (05) : S145 - S145
  • [33] Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients
    Tsubota, Akihito
    Shimada, Noritomo
    Yoshizawa, Kai
    Furihata, Tomomi
    Agata, Rie
    Yumoto, Yoko
    Abe, Hiroshi
    Ika, Makiko
    Namiki, Yoshihisa
    Chiba, Kan
    Fujise, Kiyotaka
    Tada, Norio
    Aizawa, Yoshio
    LIVER INTERNATIONAL, 2012, 32 (05) : 826 - 836
  • [34] GENOTYPIC AND PHENOTYPIC CORRELATES OF RESISTANCE IN HCV GENOTYPE 1A AND 1B INFECTED PATIENTS TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN
    Ogert, Robert A.
    McMonagle, Patricia
    Black, Stuart
    Curry, Stephanie
    Guo, Zhuyan
    Lesburg, Charles
    Chase, Robert
    Graham, Donald
    Barnard, Richard J.
    Howe, John A.
    Hazuda, Daria
    Howe, Anita Y.
    HEPATOLOGY, 2011, 54 : 794A - 795A
  • [35] Safety and tolerability of peginterferon α-2a/Ribavirin in HCV patients non-tolerant or nonresponsive to peginterferon α-2b/Ribavirin
    Rustgi, Vinod K.
    Esposito, Stephen
    Hamzeh, Fayez M.
    Shiffman, Mitchell
    GASTROENTEROLOGY, 2007, 132 (04) : A794 - A794
  • [36] HCV SPRINT-1: BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN FOR TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PREVIOUSLY UNTREATED PATIENTS
    Kwo, Paul
    Lawitz, Eric J.
    McCone, Jonathan
    Schiff, Eugene R.
    Vierling, John M.
    Pound, David
    Davis, Mitchell
    Galati, Joseph S.
    Gordon, Stuart C.
    Ravendhran, Natarajan
    Rossaro, Lorenzo
    Anderson, Frank H.
    Jacobson, Ira M.
    Rubin, Raymond
    Koury, Kenneth
    Chaudhri, Eirum I.
    Albrecht, Janice K.
    HEPATOLOGY, 2008, 48 (04) : 1027A - 1027A
  • [37] EFFECT OF BASELINE VIRAL LOAD (VL) ON RESPONSE TO BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR) IN PATIENTS INFECTED WITH HCV GENOTYPE 1
    Gordon, Stuart C.
    Reddy, K. Rajender
    McCone, Jonathan
    Jacobson, Ira M.
    Esteban, Rafael
    Pedicone, Lisa
    Shen, Junwu
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Lawitz, Eric
    HEPATOLOGY, 2011, 54 : 812A - 812A
  • [38] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [39] Interferon alpha plus ribavirin treatment in relapsers chronic HCV patients infected with genotype 1b.
    Calleja, JL
    Domper, F
    Albillos, A
    Martinez, JL
    Vera, MI
    Barrios, C
    Escartin, P
    HEPATOLOGY, 1998, 28 (04) : 211A - 211A
  • [40] Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
    Shiho Miyase
    Katsuki Haraoka
    Yoshihiro Ouchida
    Yuko Morishita
    Shigetoshi Fujiyama
    Journal of Gastroenterology, 2012, 47 : 1014 - 1021
12345